TerrAscend, a Toronto-based vertically integrated marijuana company, reported revenues of 14.6 million Canadian dollars ($10.95 million) for the quarter ended March 31, 2019, with a net loss of CA$11.2 million. The company did not report revenues for the comparable quarter in 2018. Its net loss for that period was CA$2.35 million. During the quarter, TerrAscend […]
Read MoreCanada Marijuana Industry News
Weekly Deal Watch: Cultivation and retail continues to dominate M&A cannabis activity
The cannabis cultivation and retail sector has become increasingly crowded and competitive, but successful operators can still make themselves attractive acquisition targets.
Read More
Canadian marijuana shortage dampens Aurora’s international sales
A shortfall of cannabis in Canada’s regulated market took a toll on the international sales of an industry leader, Aurora Cannabis, according to the company. The Alberta firm’s international medical cannabis sales rose nearly 40% to 4 million Canadian dollars ($3 million) in the third quarter, up from CA$2.9 million. “While we continue to expand […]
Read More
Denmark health minister: Clarity needed for European cannabis producers
Inconsistent regulations for medical cannabis across Europe create an uneven playing field that makes doing business and accessing medicine cumbersome, according to Danish Health Minister Ellen Trane Nørby.
Read More
Active conservative politicians join Canadian cannabis company
Two conservative politicians in Ontario, one representing a federal riding (electoral district) and the other provincial, have joined a British Columbia company engaged in the ancillary cannabis market.
Read More
Marijuana firm 48North reports positive revenue, net losses
48North, a vertically integrated marijuana producer based in Ontario, reported revenue of 689,203 Canadian dollars ($516,902) for the fiscal third quarter ended Mar. 31, 2019.
Read More
Australis Capital to acquire Green Therapeutics brands, cannabis assets in NV for $8M
Australis Capital, the Las Vegas-based investment group that spun off of Canadian giant Aurora Cannabis, said it will acquire certain brands and cultivation assets of Nevada’s Green Therapeutics for approximately $8 million.
Read MoreConference News
May Issue
What's next for infused products? Manufacturers must cater to demand for CBD, rapid onset and microdosing to stay ahead.Read the Issue
